Intracellular l-arginine concentration does not determine NO production in endothelial cells: Implications on the " l-arginine paradox"

Biochemical and Biophysical Research Communications

Volumn 414, Issue 4, 2011, Pages 660-663

  Shin, Soyoung ^a   Mohan, Srinidi ^a   Fung, Ho Leung ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Asymmetric dimethylarginine; L Arginine; L Arginine paradox; L Arginine transport; Nitric oxide

Indexed keywords

ARGININE; ARGININE ETHYL ESTER; CITRULLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRATE; NITRIC OXIDE; NITRITE; NITROGEN 15; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; ENDOTHELIUM CELL; FLUOROMETRY; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

ARGININE; CATIONIC AMINO ACID TRANSPORTER 1; CELL LINE; ENDOTHELIUM, VASCULAR; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 80555130991     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.112     Document Type: Article

References (21)

1. Cardounel A.J., Cui H., Samouilov A., Johnson W., Kearns P., Tsai A.L., Berka V., Zweier J.L. Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. Journal of Biological Chemistry 2007, 282:879-887.
2. Palmer R.M., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 1988, 333:664-666.
3. Baydoun A.R., Emery P.W., Pearson J.D., Mann G.E. Substrate-dependent regulation of intracellular amino acid concentrations in cultured bovine aortic endothelial cells. Biochemical and Biophysical Research Communications 1990, 173:940-948.
4. Lucotti P., Monti L., Setola E., La Canna G., Castiglioni A., Rossodivita A., Pala M.G., Formica F., Paolini G., Catapano A.L., Bosi E., Alfieri O., Piatti P. Oral l-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass. Metabolism 2009, 58:1270-1276.
5. Ruel M., Beanlands R.S., Lortie M., Chan V., Camack N., deKemp R.A., Suuronen E.J., Rubens F.D., DaSilva J.N., Sellke F.W., Stewart D.J., Mesana T.G. Concomitant treatment with oral l-arginine improves the efficacy of surgical angiogenesis in patients with severe diffuse coronary artery disease: the endothelial modulation in angiogenic therapy randomized controlled trial. Journal of Thoracic and Cardio vascular Surgery 2008, 135:762-770. e770-e761.
6. Kernohan A.F., McIntyre M., Hughes D.M., Tam S.W., Worcel M., Reid J.L. An oral yohimbine/l-arginine combination (NMI 861) for the treatment of male erectile dysfunction: a pharmacokinetic pharmacodynamic and interaction study with intravenous nitroglycerine in healthy male subjects. British Journal of Clinical Pharmacology 2005, 59:85-93.
7. Bednarz B., Jaxa-Chamiec T., Gebalska J., Herbaczynska-Cedro K., Ceremuzynski L. l-arginine supplementation prolongs exercise capacity in congestive heart failure. Kardiol Pol 2004, 60:348-353.
8. Zharikov S.I., Block E.R. Characterization of l-arginine uptake by plasma membrane vesicles isolated from cultured pulmonary artery endothelial cells. Biochimica et Biophysica Acta 1998, 1369:173-183.
9. McDonald K.K., Zharikov S., Block E.R., Kilberg M.S. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the " arginine paradox" Journal of Biological Chemistry 1997, 272:31213-31216.
10. Hardy T.A., May J.M. Coordinate regulation of l-arginine uptake and nitric oxide synthase activity in cultured endothelial cells. Free Radical Biology and Medicine 2002, 32:122-131.
11. Zani B.G., Bohlen H.G. Transport of extracellular l-arginine via cationic amino acid transporter is required during in vivo endothelial nitric oxide production. American Journal of Physiology - Heart and Circulatory Physiology 2005, 289:H1381-1390.
12. Edgell C.J., McDonald C.C., Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proceedings of the National Academy of Sciences of the United States of America 1983, 80:3734-3737.
13. Shin S., Fung S.M., Mohan S., Fung H.L. Simultaneous bioanalysis of l-arginine, l-citrulline, and dimethylarginines by LC-MS/MS. Journal of Chromatography B - Analytical Technologies in the Biomedical and Life Sciences 2011, 879:467-474.
14. 15 N-nitrite for cellular studies of l-arginine action. Journal of Pharmaceutical and Biomedical Analysis 2011, 56:1127-1131.
15. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
16. S. Shin, l-Arginine Transport, Metabolism and Action, Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, 2011.
17. Gonzalez M., Gallardo V., Rodriguez N., Salomon C., Westermeier F., Guzman-Gutierrez E., Abarzua F., Leiva A., Casanello P., Sobrevia L. Insulin-stimulated l-arginine transport requires SLC7A1 gene expression and is associated with human umbilical vein relaxation. Journal of Cellular Physiology 2011.
18. S. Shin, H.-L. Fung, Role of asymmetric dimethylarginine in l-arginine paradox: transport and metabolism considerations, in: AAPS Annual Meeting and Exposition, The AAPS Journal, 2009, abstract #1103.
19. Bode-Boger S.M., Scalera F., Ignarro L.J. The l-arginine paradox: importance of the l-arginine/asymmetrical dimethylarginine ratio. Pharmacology and Therapeutics 2007, 114:295-306.
20. S. Shin, H.-L. Fung, Extracellular l-arginine transport, not its intracellular concentration, determines l-arginine action in endothelial cells, in: 2010 FIP Pharmaceutical Sciences World Congress, The AAPS Journal, 2010, pp. T3392.
21. Tangphao O., Grossmann M., Chalon S., Hoffman B.B., Blaschke T.F. Pharmacokinetics of intravenous and oral l-arginine in normal volunteers. British Journal of Clinical Pharmacology 1999, 47:261-266.